Amarantus Bioscience Holdings Inc (AMBS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2010 | 04-2010 | 01-2010 | 12-2009 | 10-2009 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -113 | -25 | -1 | 0 | N/A |
| Depreciation Amortization | 1 | 1 | 0 | 0 | N/A |
| Accounts payable and accrued liabilities | 199 | 24 | 0 | 0 | N/A |
| Other Working Capital | -37 | 24 | 0 | N/A | N/A |
| Other Operating Activity | -158 | -24 | 0 | 0 | 0 |
| Operating Cash Flow | $-107 | $0 | $0 | $0 | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -23 | N/A | N/A | 0 | N/A |
| Investing Cash Flow | $-23 | $N/A | $N/A | $0 | $N/A |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 450 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $450 | $N/A | $N/A | $0 | $N/A |
| Beginning Cash Position | 1 | 0 | 0 | 0 | N/A |
| End Cash Position | 321 | 0 | 0 | 0 | N/A |
| Net Cash Flow | $319 | $0 | $0 | $0 | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -107 | 0 | 0 | 0 | N/A |
| Capital Expenditure | -23 | N/A | N/A | 0 | N/A |
| Free Cash Flow | -131 | 0 | 0 | 0 | 0 |